Erratum: Expression of Concern: Distinct Characteristics of Circulating Vascular Endothelial Growth Factor-A and C Levels in Human Subjects (PLoS ONE (2011) 6:12 (e29351) DOI: 10.1371/journal.pone.0029351);Distinct characteristics of circulating vascular endothelial growth factor-A and C levels in human subjects

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Wada, Hiromichi ^a   Ura, Shuichi ^a   Kitaoka, Shuji ^a   Satoh Asahara, Noriko ^a   Horie, Takahiro ^b,c   Ono, Koh ^a,c   Takaya, Tomohide ^a,c   Takanabe Mori, Rieko ^a   Akao, Masaharu ^a   Abe, Mitsuru ^a   Morimoto, Tatsuya ^a,d   Murayama, Toshinori ^b   Yokode, Masayuki ^b   Fujita, Masatoshi ^c   Shimatsu, Akira ^a   Hasegawa, Koji ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOREACTIVE INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA SINUS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; LIPID DIET; MALE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WAIST CIRCUMFERENCE; ANIMAL; BLOOD; GENE EXPRESSION REGULATION; LIPID METABOLISM; METABOLISM; MIDDLE AGED;

ANIMALS; APOLIPOPROTEINS E; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LIPID METABOLISM; MALE; MICE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 83755196498     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0278795     Document Type: Erratum

References (22)

1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, et al. (1999) The disease burden associated with overweight and obesity. JAMA 282: 1523-1529.
2. Abate N, (2000) Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications 14: 154-174.
3. Crandall DL, Hausman GJ, Kral JG, (1997) A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4: 211-232.
4. Lohela M, Bry M, Tammela T, Alitalo K, (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21: 154-165.
5. Hausman GJ, Richardson RL, (2004) Adipose tissue angiogenesis. J Anim Sci 82: 925-934.
6. Nishimura S, Manabe I, Nagasaki M, Hosoya Y, Yamashita H, et al. (2007) Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56: 1517-1526.
7. Silha JV, Krsek M, Sucharda P, Murphy LJ, (2005) Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond) 29: 1308-1314.
8. Loebig M, Klement J, Schmoller A, Betz S, Heuck N, et al. (2010) Evidence for a relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young men. PLoS One 5: e12610.
9. Sandhofer A, Tatarczyk T, Kirchmair R, Iglseder B, Paulweber B, et al. (2009) Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis 206: 265-269.
10. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5: 74-80.
11. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, et al. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425.
12. Tamura M, Ohta Y, (2003) Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis. Cancer 9: 1217-1222.
13. Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, et al. (2004) Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest 126: 342-346.
14. Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, et al. (2005) Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer 103: 724-730.
15. Wang TB, Deng MH, Qiu WS, Dong WG, (2007) Association of serum vascular endothelial growth factor-C and lymphatic vessel density with lymph node metastasis and prognosis of patients with gastric cancer. World J Gastroenterol 13: 1794-1797.
16. Mouawad R, Spano JP, Comperat E, Capron F, Khayat D, (2009) Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome. Eur J Cancer 45: 1407-1414.
17. Wada H, Satoh N, Kitaoka S, Ono K, Morimoto T, et al. (2010) Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis 208: 512-517.
18. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A et al, (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
19. Machnik A, Neuhofer W, Jantsch J, Dahlmann A, Tammela T, et al. (2009) Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 15: 545-552.
20. Nakano T, Nakashima Y, Yonemitsu Y, Sumiyoshi S, Chen YX, et al. (2005) Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries. Hum Pathol 36: 330-340.
21. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, et al. (1998) Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98: 2108-2116.
22. Albuquerque RJ, Hayashi T, Cho WG, Kleinman ME, Dridi S, et al. (2009) Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 15: 993-994.